Evidence map›Paper›PMID 34815382›Full record

ArticleCell death & disease2021

Nerve growth factor promotes lysyl oxidase-dependent chondrosarcoma cell metastasis by suppressing miR-149-5p synthesis.

Huey-En Tzeng, Syuan-Ling Lin, Louis Anoop Thadevoos, Ming-Yu Lien, Wei-Hung Yang, Chih-Yuan Ko, Chih-Yang Lin, Yu-Wen Huang, Ju-Fang Liu, Yi-Chin Fong and 2 more

Open access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Tumor-Suppressive and Oncogenic Roles of microRNA-149-5p in Human Cancers.International journal of molecular sciences · 2022
    Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

Huey-En Tzeng *Ph.D. Program for Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan.
Syuan-Ling Lin *Translational Medicine Research Center, China Medical University Hospital, Taichung, Taiwan.
Louis Anoop ThadevoosInternational Master Program of Biomedical Sciences, China Medical University, Taichung, Taiwan.
Ming-Yu LienDivision of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan.
Wei-Hung YangSchool of Chinese Medicine, China Medical University, Taichung, Taiwan.
Chih-Yuan KoDepartment of Orthopedic Surgery, China Medical University Hospital, Taichung, Taiwan.ORCID http://orcid.org/0000-0001-7752-2833
Chih-Yang LinDepartment of Pharmacology, School of Medicine, China Medical University, Taichung, Taiwan.ORCID http://orcid.org/0000-0001-5310-6069
Yu-Wen HuangGraduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan.
Ju-Fang LiuSchool of Oral Hygiene, College of Oral Medicine, Taipei Medical University, Taipei, Taiwan.
Yi-Chin FongDepartment of Sports Medicine, College of Health Care, China Medical University, Taichung, Taiwan.
Hsien-Te ChenDepartment of Orthopedic Surgery, China Medical University Hospital, Taichung, Taiwan. bonekid1@gmail.com.ORCID http://orcid.org/0000-0002-5035-4005
Chih-Hsin TangDepartment of Pharmacology, School of Medicine, China Medical University, Taichung, Taiwan. chtang@mail.cmu.edu.tw.ORCID http://orcid.org/0000-0002-7113-8352
China Medical University · TWAsia University · TWNational Taichung University of Science and Technology · TWTaipei Medical University · TWTaipei Medical University Hospital · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chondrosarcoma is a malignancy of soft tissue and bone that has a high propensity to metastasize to distant organs. Nerve growth factor (NGF) is critical for neuronal cell growth, apoptosis, and differentiation, and also appears to promote the progression and metastasis of several different types of tumors, although the effects of NGF upon chondrosarcoma mechanisms are not very clear. We report that NGF facilitates lysyl oxidase (LOX)-dependent cellular migration and invasion in human chondrosarcoma cells, and that NGF overexpression enhances lung metastasis in a mouse model of chondrosarcoma. NGF-induced stimulation of LOX production and cell motility occurs through the inhibition of miR-149-5p expression, which was reversed by PI3K, Akt, and mTOR inhibitors and their respective short interfering RNAs. Notably, levels of NGF and LOX expression correlated with tumor stage in human chondrosarcoma samples. Thus, NGF appears to be a worthwhile therapeutic target for metastatic chondrosarcoma.

Indexed as

AnimalsCell MovementChondrosarcomaExtracellular Matrix ProteinsHumansMiceMicroRNAsNeoplasm InvasivenessNeoplasm MetastasisNerve Growth FactorProtein-Lysine 6-OxidaseExtracellular Matrix ProteinsLox protein, mouseMicroRNAsMIRN149 microRNA, mouseNerve Growth FactorProtein-Lysine 6-Oxidase

Identifiers

PMID34815382
PMCPMC8611026
OpenAlexW3186862546

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.